In the News: April 20, 2018


Here is your weekly round-up of pharmacy news from the last week. Enjoy!

"As Louisiana’s pharmacy board Tuesday started awarding the licenses to dispense medical cannabis, a handful of state lawmakers slammed the process as unfair to small, locally-owned pharmacists."

"Congress hasn’t done much to rein in the costs of prescription drugs, so states are taking matters into their own hands.

While lawmakers have railed against pharmaceutical executives and accused them of jacking up prices, they haven’t passed major legislation on the issue. That lack of action has, in part, spurred state legislatures to consider a slew of bills aimed at decreasing the cost of drugs, increasing price transparency and cracking down on controversial industry practices."

"The American Pharmacists Association, the American Medical Association and the Pharmacists Society of the State of New York have called for state and local laws prohibiting tobacco sales in pharmacies because they believe that doing so supports the public health and social welfare of the communities in which they practice."

"States continue to battle budget-busting prices of prescription drugs. But a federal court decision could limit the weapons available to them — underscoring the challenge states face as they, in the absence of federal action, go one-on-one against the powerful drug industry."

"Noting that until now, PBMs have not been sued for the opioid crisis, in February, a south Texas county included the three largest PBMs in a nationwide lawsuit, which focused on the opioid epidemic. Their inclusion was due to their role in allowing access to prescription opioids."

"TALLAHASSEE, Fla. - Starting July 1, pharmacists across the state of Florida will finally be able to tell patients if they can save money on their medications by paying cash or by using insurance."

"The head of the Food and Drug Administration said many people are to blame for high drug prices, including the agency itself."

"LAS VEGAS - More law enforcement agencies in the state are carrying the opioid overdose reversal drug -- Naloxone."

"Expanding pharmacist vaccination authorizations would bend the healthcare cost curve."